Mechanism of Action: M2 Protein Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: M2 Protein Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 070589-001 | Aug 5, 1986 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Humanwell Puracap | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 214580-001 | Dec 20, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Athem | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET;ORAL | 210215-001 | Mar 10, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alembic | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 208966-001 | Jun 21, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | CAPSULE;ORAL | 210129-001 | Mar 2, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alembic | AMANTADINE HYDROCHLORIDE | amantadine hydrochloride | TABLET;ORAL | 214284-001 | Oct 15, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
